Osstell Adds Next Level in Implant Stability Measurement Instruments
Gothenburg, Sweden June 20, 2018: Osstell, the developer of the ISQ diagnostic technology (Implant Stability Quotient), now presents the next leap in the evolution of implant diagnostic instrumentation: The Osstell Beacon, an innovative and highly intuitive tool designed to guide implant treatments for more predictable results. Osstell’s patented technology allow clinicians working with implants to make decisions based on reliable and objective stability values when determining the course of treatment for each patient. The procedure can be used to measure primary implant stability, observe osseointegration based on secondary stability readings and determine the best possible time for loading the implant, thereby helping to prevent failures, shortening healing time and ensuring high quality.
The dental implant market has changed over the past few years. There are now more dentists with less experience within implantology and a generation shift with different expectations is coming. Clinicians are facing more complex decisions as there is an increase in patients with risk factors as well as increasing demands for shorter treatment times. Digital planning and workflows are redefining protocols and techniques. There is thus a need for objective tools to increase efficiency, and to guide and optimize the implant treatment for both complex and more straight-forward cases, making ISQ diagnostics a necessary and objective key value to help improve outcomes and quality.
“We have listened to our users who need easy to use and intuitive tools to assess implant stability. Accordingly, we have developed a complement to the more comprehensive Osstell IDx to meet the needs from both large university clinics and small private practices. Although advanced on the inside, we believe that the Osstell Beacon will be appreciated for its ease of use and making the stability measurement very intuitive. Having the ISQ data presented with a colored stability guidance, which is a result of the clinical evidence from using our ISQ scale, will be especially valuable for clinicians that are new to our technology.”, says Mr. Stefan Horn, VP Product Development, Osstell.
In the industry today, there is a lot of talk about connectivity, Internet of Things and big data. With this comes a strong need to, not only capturing the data, but also to be able to provide context to the numbers, to turn it into something useful and insightful. “That’s why we are continuously focusing on enhancing connectivity and Osstell Connect, our online service where you can analyze your data and get relevant insights of your implant treatment performance. We believe this will only become more and more valuable for the clinicians.”, Mr. Horn continued. Both the Osstell Beacon and the Osstell IDx give you access to Osstell Connect.
“Osstell’s innovative and patented technology allow dentists around the world to make dental implant treatments even safer and more predictable, and thereby helping clinicians improve patient confidence and comfort. We always aim to serve our customers and users with even better products and services as well as helping them to provide best practice services to their customers – the patients. Patients’ well-being is always the top priority. With this – the Osstell Beacon – being newest addition we take another important major step towards making our technology, products and our approach even more accessible”, says Mr Jonas Ehinger, CEO of Osstell.
The Osstell Beacon will be announced and shown at the Europerio 9 event in Amsterdam, Netherlands on June 20, 2018. Initially, it will be available in the EU and the US upon regulatory approval. Additional markets will follow pending regulatory approval processes.